iRhythm Technologies, Inc. (NASDAQ:IRTC – Get Free Report) CFO Brice Bobzien sold 1,372 shares of the business’s stock in a transaction that occurred on Friday, August 9th. The stock was sold at an average price of $70.34, for a total transaction of $96,506.48. Following the completion of the transaction, the chief financial officer now directly owns 24,428 shares of the company’s stock, valued at approximately $1,718,265.52. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link.
iRhythm Technologies Price Performance
Shares of IRTC opened at $66.49 on Thursday. The firm has a market capitalization of $2.07 billion, a PE ratio of -15.72 and a beta of 1.25. The company has a debt-to-equity ratio of 7.13, a current ratio of 7.10 and a quick ratio of 6.95. iRhythm Technologies, Inc. has a 1-year low of $64.35 and a 1-year high of $124.11. The company’s fifty day moving average price is $92.26 and its 200-day moving average price is $102.48.
iRhythm Technologies (NASDAQ:IRTC – Get Free Report) last announced its quarterly earnings data on Thursday, August 1st. The company reported ($0.61) earnings per share for the quarter, beating analysts’ consensus estimates of ($0.89) by $0.28. The firm had revenue of $148.05 million for the quarter, compared to analyst estimates of $146.15 million. iRhythm Technologies had a negative net margin of 24.50% and a negative return on equity of 75.14%. The business’s quarterly revenue was up 19.3% compared to the same quarter last year. During the same period in the previous year, the company earned ($0.61) earnings per share. On average, equities research analysts predict that iRhythm Technologies, Inc. will post -3.22 EPS for the current year.
Wall Street Analysts Forecast Growth
View Our Latest Analysis on IRTC
Institutional Investors Weigh In On iRhythm Technologies
Several hedge funds have recently added to or reduced their stakes in IRTC. International Assets Investment Management LLC purchased a new stake in iRhythm Technologies in the fourth quarter valued at $92,000. Mirae Asset Global Investments Co. Ltd. boosted its holdings in iRhythm Technologies by 4.8% in the fourth quarter. Mirae Asset Global Investments Co. Ltd. now owns 72,835 shares of the company’s stock valued at $7,796,000 after purchasing an additional 3,307 shares during the last quarter. WCM Investment Management LLC boosted its holdings in iRhythm Technologies by 61.4% in the fourth quarter. WCM Investment Management LLC now owns 133,195 shares of the company’s stock valued at $14,497,000 after purchasing an additional 50,673 shares during the last quarter. Handelsbanken Fonder AB raised its position in shares of iRhythm Technologies by 3.3% in the fourth quarter. Handelsbanken Fonder AB now owns 6,239 shares of the company’s stock worth $668,000 after acquiring an additional 200 shares during the period. Finally, State of New Jersey Common Pension Fund D raised its position in shares of iRhythm Technologies by 25.8% in the fourth quarter. State of New Jersey Common Pension Fund D now owns 29,300 shares of the company’s stock worth $3,136,000 after acquiring an additional 6,012 shares during the period.
iRhythm Technologies Company Profile
iRhythm Technologies, Inc, a digital healthcare company, engages in the design, development, and commercialization of device-based technology to provide ambulatory cardiac monitoring services to diagnose arrhythmias in the United States. It offers Zio services, an ambulatory monitoring solution, including long-term and short-term continuous monitoring and mobile cardiac telemetry monitoring services.
Recommended Stories
- Five stocks we like better than iRhythm Technologies
- What Is WallStreetBets and What Stocks Are They Targeting?
- Brinker International’s Price Dip is an Appetizing Entry Point
- How to Calculate Retirement Income: MarketBeat’s Calculator
- 3 Stocks That Could Beat the September Blues
- Why Are Stock Sectors Important to Successful Investing?
- Canopy Growth Stock: Can It Sustain Recent Gains?
Receive News & Ratings for iRhythm Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for iRhythm Technologies and related companies with MarketBeat.com's FREE daily email newsletter.